Beta-Amyrin

Beta-Amyrin

SCHEMBL1696465

CC1(C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@@H](O)C(C)(C)C5CC[C@]43C)[C@H]2C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 2/20 1.00
▸ ALOX5 P09917 4/20 0.79
▸ CES1 P23141 3/20 0.77
▸ CES2 O00748 1/20 0.77
▸ PTPN1 P18031 9/20 0.77
▸ AKR1B10 O60218 3/20 0.77
▸ AKR1B1 P15121 1/20 0.77
▸ POLB P06746 3/20 0.76
▸ PTPN2 P17706 3/20 0.76
▸ PSMB11 A5LHX3 2/20 0.76
▸ PSMA7 O14818 2/20 0.76
▸ PLA2G1B P04054 2/20 0.76
▸ PTPRC P08575 2/20 0.76
▸ PTPRF P10586 2/20 0.76
▸ F3 P13726 2/20 0.76
▸ PSMB1 P20618 2/20 0.76
▸ ACP1 P24666 2/20 0.76
▸ PSMA1 P25786 2/20 0.76
▸ PSMA2 P25787 2/20 0.76
▸ PSMA3 P25788 2/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Beta-Amyrin SCHEMBL17124229 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL12313094 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL18687837 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL377754 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL14828378 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL1696463 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL3119711 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL18376076 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL14226156 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL2025280 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536288-B1 A NOVEL BOSWELLIA LOW POLAR GUM RESIN EXTRACT AND ITS SYNERGISTIC COMPOSITIONS LAILA NUTRACEUTICALS (IN) 2022-06-22 — — EP claimed
US-20190175678-A1 SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACT LAILA NUTRA PRIVATE LIMITED (IN) 2019-06-13 — — US claimed
US-10286023-B2 Compositions comprising non-acidic Boswellia oil fraction as a bio-enhancer for enhancing bioavailability of biological agents LAILA NUTRACEUTICALS (IN) 2019-05-14 — — US claimed
US-10206964-B2 Synergistic anti-inflammatory compositions comprising Boswellia serrata extract LAILA NUTRACEUTICALS (IN) 2019-02-19 — — US claimed
US-20150290270-A1 SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACT LAILA NUTRACEUTICALS 2015-10-15 — — US claimed
US-9101599-B2 Synergistic anti-inflammatory compositions comprising Boswellia serrata extracts LAILA NUTRACEUTICALS (US) 2015-08-11 — — US claimed
US-8551496-B2 Boswellia low polar gum resin extract and its synergistic compositions LAILA NUTRACEUTICALS (IN) 2013-10-08 — — US claimed
US-20120301432-A1 NOVEL BOSWELLIA LOW POLAR GUM RESIN EXTRACT AND ITS SYNERGISTIC COMPOSITIONS LAILA NUTRACEUTICALS (IN) 2012-11-29 — — US claimed
US-20110159120-A1 SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACTS LAILA NUTRACEUTICALS (IN) 2011-06-30 — — US claimed
WO-2010029578-A2 SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACTS GOKARAJU GANGA RAJU (IN) 2010-03-18 — — WO claimed
EP-2536288-B1 A NOVEL BOSWELLIA LOW POLAR GUM RESIN EXTRACT AND ITS SYNERGISTIC COMPOSITIONS LAILA NUTRACEUTICALS (IN) 2022-06-22 — — EP disclosed
US-20190175678-A1 SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACT LAILA NUTRA PRIVATE LIMITED (IN) 2019-06-13 — — US disclosed
US-10286023-B2 Compositions comprising non-acidic Boswellia oil fraction as a bio-enhancer for enhancing bioavailability of biological agents LAILA NUTRACEUTICALS (IN) 2019-05-14 — — US disclosed
US-10206964-B2 Synergistic anti-inflammatory compositions comprising Boswellia serrata extract LAILA NUTRACEUTICALS (IN) 2019-02-19 — — US disclosed
US-9795646-B2 Boswellia oil, its fractions and compositions for enhancing brain function LAILA NUTRACEUTICALS (IN) 2017-10-24 — — US disclosed
WO-2011151840-A2 COMPOSITIONS COMPRISING NON-ACIDIC BOSWELLIA OIL FRACTION AS A BIO-ENHANCER FOR ENHANCING THE BIOAVAILABILITY OF BIOLOGICAL AGENTS LAILA NUTRACEUTICALS (IN) 2011-12-08 — — WO disclosed
WO-2011114350-A2 BOSWELLIA OIL, ITS FRACTIONS AND COMPOSITIONS FOR ENHANCING BRAIN FUNCTION LAILA NUTRACEUTICALS (IN) 2011-09-22 — — WO disclosed
WO-2011099029-A1 A NOVEL BOSWELLIA LOW POLAR GUM RESIN EXTRACT AND ITS SYNERGISTIC COMPOSITIONS LAILA NUTRACEUTICALS (IN) 2011-08-18 — — WO disclosed
US-20110159120-A1 SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACTS LAILA NUTRACEUTICALS (IN) 2011-06-30 — — US disclosed
WO-2010029578-A2 SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACTS GOKARAJU GANGA RAJU (IN) 2010-03-18 — — WO disclosed
Send feedback